Skip to search.
 TSX Up 0.24% TSX Ventures Up 0.49%

More On NPSP

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

NPS Pharmaceuticals, Inc. (NPSP)

-NasdaqGS
45.97 0.00(0.00%) Feb 20, 3:59PM EST
Prev Close:45.97
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:43.82
Beta:-0.43
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:22.19 - 46.01
Volume:0
Avg Vol (3m):3,742,990
Market Cap:4.99B
P/E (ttm):N/A
EPS (ttm):-0.08
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NPSP 0.00%4.99B
ABTUp 0.30%63.42B
BIIBUp 1.89%63.04B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :N/A
Quarterly EPS Est (Mar-15) :N/A
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NPS Pharmaceuticals, Inc., a biopharmaceutical company, provides therapeutic products for the treatment of gastrointestinal and endocrine disorders. The company offers Gattex for the treatment of adult patients with short bowel syndrome (SBS) who ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback